Ex vivo-expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin grafts.

Dendritic cells (DCs) are known to regulate immune responses by inducing both central and peripheral tolerance. DCs play a vital role in negative selection of developing thymocytes by deleting T cells with high-affinity for self-peptide-major histocompatibility complexes. In the periphery, DCs mediate peripheral tolerance by promoting regulatory T-cell development, induction of T-cell unresponsiveness, and deletion of activated T cells. We studied whether allogeneic DCs, obtained from bone marrow cultured with either Flt3L (FLDCs) or granulocyte-macrophage colony-stimulating factor (GMDCs), could induce allospecific central and peripheral tolerance after IV injection; B cells were used as a control. The results showed that only FLDCs reached the thymus after injection and that these cells induced both central and peripheral tolerance to donor major histocompatibility complexes. For central tolerance, injection of FLDCs induced antigen-specific clonal deletion of both CD8 and CD4 single-positive thymocytes. For peripheral tolerance, injection of FLDCs induced donor-specific T-cell unresponsiveness and prolonged survival of donor-derived skin grafts. Tolerance induction by adoptive transfer of FLDCs could be a useful approach for promoting graft acceptance after organ transplantation.

[1]  L. Klein,et al.  Antigen presentation in the thymus for positive selection and central tolerance induction , 2009, Nature Reviews Immunology.

[2]  Arup K. Chakraborty,et al.  The impact of negative selection on thymocyte migration in the medulla , 2009, Nature Immunology.

[3]  J. Park,et al.  Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus , 2009, The Journal of experimental medicine.

[4]  D. Voehringer,et al.  Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity , 2009, The Journal of experimental medicine.

[5]  L. Zhang,et al.  The Allogeneic but not Syngeneic Dendritic Cells Effectively Generated Regulatory T Cells from Total Cd4+ Population without Exogenous Cytokines , 2009, Scandinavian journal of immunology.

[6]  Steffen Jung,et al.  Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. , 2008, Immunity.

[7]  J. Villadangos,et al.  Antigen-presentation properties of plasmacytoid dendritic cells. , 2008, Immunity.

[8]  Yuekang Xu,et al.  Differential Development of Murine Dendritic Cells by GM-CSF versus Flt3 Ligand Has Implications for Inflammation and Trafficking1 , 2007, The Journal of Immunology.

[9]  Carl G. Figdor,et al.  Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting , 2007, Nature Reviews Immunology.

[10]  R. Steinman,et al.  Taking dendritic cells into medicine , 2007, Nature.

[11]  A. Thomson,et al.  Tolerogenic dendritic cells and the quest for transplant tolerance , 2007, Nature Reviews Immunology.

[12]  J. Villadangos,et al.  Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo , 2007, Nature Reviews Immunology.

[13]  P. Guermonprez,et al.  Antigen presentation by B lymphocytes: how receptor signaling directs membrane trafficking. , 2007, Current opinion in immunology.

[14]  R. Bonasio,et al.  Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus , 2006, Nature Immunology.

[15]  James M. Wettenhall,et al.  Signal Regulatory Protein Molecules Are Differentially Expressed by CD8− Dendritic Cells1 , 2006, The Journal of Immunology.

[16]  C. Larsen,et al.  Transplant Tolerance in Non‐Human Primates: Progress, Current Challenges and Unmet Needs , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  F. Tacke,et al.  Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts , 2006, Nature Immunology.

[18]  Li Wu,et al.  Cutting Edge: Generation of Splenic CD8+ and CD8− Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures1 , 2005, The Journal of Immunology.

[19]  R. Abe,et al.  Effect of Inflammation on Costimulation Blockade‐Resistant Allograft Rejection , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  G. Trinchieri,et al.  Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.

[21]  L. Turka,et al.  Tregs and transplantation tolerance. , 2004, The Journal of clinical investigation.

[22]  Michael J. Bevan,et al.  Central Tolerance to Tissue-specific Antigens Mediated by Direct and Indirect Antigen Presentation , 2004, The Journal of experimental medicine.

[23]  T. Starzl Chimerism and tolerance in transplantation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Strom,et al.  Critical Role of OX40 in CD28 and CD154-Independent Rejection1 , 2004, The Journal of Immunology.

[25]  Li Zhang,et al.  Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. , 2002, Blood.

[26]  Hidehiro Kishimoto,et al.  The thymus and negative selection , 2002, Immunological reviews.

[27]  A. Theofilopoulos,et al.  Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival. , 2002, The Journal of clinical investigation.

[28]  Michel C. Nussenzweig,et al.  Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.

[29]  M. Sykes,et al.  Mixed chimerism and transplant tolerance. , 2001, Immunity.

[30]  M. Roncarolo,et al.  Differentiation of T Regulatory Cells by Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[31]  E. Palmer,et al.  Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1 , 2001, The Journal of Immunology.

[32]  C. Maliszewski,et al.  Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. , 2000, Blood.

[33]  G. Schuler,et al.  Immature dendritic cells generated with low doses of GM‐CSF in the absence of IL‐4 are maturation resistant and prolong allograft survival in vivo , 2000, European journal of immunology.

[34]  C. Larsen,et al.  Cutting Edge: Administration of Anti-CD40 Ligand and Donor Bone Marrow Leads to Hemopoietic Chimerism and Donor-Specific Tolerance Without Cytoreductive Conditioning1 , 2000, The Journal of Immunology.

[35]  G. Schuler,et al.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.

[36]  R. Noelle,et al.  Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. , 1998, The Journal of clinical investigation.

[37]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[38]  M. Bevan,et al.  Antigen‐specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection , 1997, European journal of immunology.

[39]  R. Cummings,et al.  P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. , 1996, Blood.

[40]  S. Kienle,et al.  Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. , 1996, Journal of immunology.

[41]  P. Linsley,et al.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways , 1996, Nature.

[42]  A. Lanzavecchia,et al.  Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1. , 1993, Immunology.

[43]  Shalin H. Naik,et al.  Steady-state and inflammatory dendritic-cell development , 2007, Nature Reviews Immunology.

[44]  L. Kanz,et al.  Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. , 1998, Blood.